Clinical Trials on Ovarian Neoplasms in Australia

Total 4870 results

Peter MacCallum Cancer Centre, Australia

Completed

A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases (FASTRACK)

Cancer

Australia
Medical University of Vienna

Unknown

Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer (CARCINOSIS)

Colorectal Cancer | Peritoneal Metastasis

Austria
BeiGene

Completed

Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies

B-cell Malignancies

Australia
Cooperative Research Centre for Biomedical Imaging...

Unknown

Of 18F MEL050 Using PET/CT in Metastatic Melanoma (MEL050)

Metastatic Melanoma

Australia
Peter MacCallum Cancer Centre, Australia
United States Department of Defense; Advanced Accelerator Applications; Australian... and other collaborators

Active, not recruiting

In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy (UpFrontPSMA)

Metastatic Hormone Naive Prostate Cancer

Australia
Hoffmann-La Roche

Completed

A Study of RO5212054 (PLX3603) in Participants With BRAF V600-Mutated Advanced Solid Tumors

Neoplasms

Australia, Spain, Denmark
Medicenna Therapeutics, Inc.
Merck Sharp & Dohme LLC

Recruiting

A Beta-only IL-2 ImmunoTherapY Study (ABILITY-1)

Clear Cell Renal Cell Carcinoma | Cervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumor | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Skin Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Primary Peritoneal Cancer | Endometrial Carcinoma and other conditions

United States, Australia, Korea, Republic of, Canada
AskGene Pharma, Inc.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase 1 Study of ASKG315 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Australia
AbbVie (prior sponsor, Abbott)

Completed

An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types

Advanced Solid Tumors

Australia
Medical University of Vienna

Completed

Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases

Brain Metastases

Austria
Viralytics

Completed

A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients (PSX-X03)

Stage IV Melanoma

Australia
Professor Michael Bourke

Completed

Soft Coagulation for the Prevention of Adenoma Recurrence (SCAR)

Colonic Adenomas

Australia
Queensland Centre for Gynaecological Cancer

Completed

Uterine Papillary Serous Cancer (UPSC) Trial

Uterine Cancer

Australia
University of Sydney

Completed

ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial

Colorectal Cancer Screening

Australia
South West Sydney Local Health District

Unknown

Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (DOSE-HEP)

Hepatocellular Cancer

Australia
OncoC4, Inc.
Avance Clinical; OncoC4 AU Pty Ltd

Recruiting

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors (PRESERVE-009)

Melanoma | Renal Cell Carcinoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Fallopian Tube Cancer | Non Small Cell Lung Cancer | Bile Duct Cancer | Bladder Cancer | Endometrial Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Primary Peritoneal... and other conditions

Australia
Shanghai Henlius Biotech

Recruiting

HLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid Tumors

Non-small Cell Lung Cancer | Locally Advanced or Metastatic Solid Tumors

Australia
Luye Pharma Group Ltd.

Enrolling by invitation

to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers

Parkinson's Disease

Australia
Biotech Equity Partners Pty Ltd

Unknown

A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer (FP253-GDEPT)

Prostate Cancer

Australia
Innate Immunotherapeutics
Syneos Health

Completed

Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis

New Zealand, Australia
Kirby Institute

Active, not recruiting

Study of Pomalidomide in Anal Cancer Precursors (SPACE)

High Grade Squamous Intra-epithelial Lesion (HSIL)

Australia
GC Cell Corporation

Not yet recruiting

Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201

Breast Cancer | Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

Australia
Western Sydney Local Health District

Unknown

Sunitinib Drug Levels and Outcomes in Kidney Cancer (CRESTO)

Renal Cell Carcinoma

Australia
Olivia Newton-John Cancer Research Institute
Humanigen, Inc.

Completed

A Trial of KB004 in Patients With Glioblastoma

Glioblastoma

Australia
University of Sydney
Western Sydney Local Health District

Not yet recruiting

Respiratory Adaptive Computed Tomography: Feasibility Study on Real-Time Gated 4DCT for Lung Cancer Radiotherapy (REACT)

Lung Cancer

Australia
Murdoch Childrens Research Institute

Completed

Clinical Hypnosis and Home Blood Pressure Monitoring in Children With Neurofibromatosis Type 1

Hypertension | Blood Pressure | Neurofibromatosis 1

Australia
Western Sydney Local Health District

Completed

Cold Snare Polypectomy Versus Endoscopic Mucosal Resection for Colonic Sessile Serrated Polyps (CSP-EMR)

Colorectal Cancer | Adenoma

Australia
University of Sydney
National Health and Medical Research Council, Australia

Unknown

Randomised Controlled Trial of a Literacy Sensitive Decision Aid for Bowel Cancer Screening

Colorectal Neoplasms

Australia
Multitude Therapeutics Inc.

Recruiting

AMT-116 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

Australia
Bio-Thera Solutions

Terminated

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients

Advanced Solid Tumour

Australia
Alphamab (Australia) Co Pty Ltd.

Unknown

Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

Australia
Northern Sydney and Central Coast Area Health Service
Merck KGaA, Darmstadt, Germany

Unknown

Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene (ExCentric)

Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4

Australia
Asbestos Diseases Research Foundation
EnGeneIC Limited

Completed

MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC

Non-Small Cell Lung Cancer | Malignant Pleural Mesothelioma

Australia
Children's Hospital Los Angeles
National Cancer Institute (NCI)

Unknown

Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors

Brain and Central Nervous System Tumors

United States, Australia, Canada
Peter MacCallum Cancer Centre, Australia

Recruiting

Hepatocellular Carcinoma Imaging Using PSMA PET/CT (HepaSMART)

Hepatocellular Carcinoma

Australia
Western Sydney Local Health District

Completed

Comparison of the Benefit of Chromoendoscopy in Addition to High Definition White Light and Narrow Band Imaging for the Prediction of Submucosal Invasive Cancer in Colonic Lesions (LANS)

Colorectal Cancer | Colon Polyp | Colonic Adenoma | Submucosal Invasive Colon Adenocarcinoma

Australia
University of Sydney
Western Sydney Local Health District

Active, not recruiting

Collection of Head Images During Radiotherapy (CHIRP)

Head and Neck Neoplasms | Radiation Therapy Complication

Australia
Cancer Therapeutics Research Group
National Cancer Institute (NCI)

Completed

Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer

Prostate Cancer

Australia, Singapore, Hong Kong
Professor Michael Bourke

Recruiting

Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach (OERS)

Adenoma, Villous

Australia
Calvary Mater Newcastle, Australia
Abbott

Completed

PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) (PROCITT)

Prostate Cancer

Australia
NYU Langone Health
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer

Brain and Central Nervous System Tumors

United States, Australia
Western Sydney Local Health District
Bristol-Myers Squibb; University of Western Sydney

Recruiting

Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity (ICEMELT)

Melanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Gastric Cancer | Mesothelioma | Endometrial Cancer | Lung Cancer, Nonsmall Cell

Australia
St Vincent's Hospital, Sydney

Recruiting

Bipolar Androgen Therapy + Carboplatin in mCRPC (HiTeCH)

Castration-resistant Prostate Cancer | Homologous Recombination Deficiency

Australia
Professor Michael Bourke

Recruiting

Upper GI Outcomes Following EMR (UGI-EMR)

Adenoma, Villous

Australia
Professor Michael Bourke

Active, not recruiting

Comparison Between White Light Endoscopy and Bright Narrow Band Imaging in Diagnosis Colonic Adenomas. (WLEvB-NBI)

Colonic Adenomas

Australia
Eli Lilly and Company

Completed

Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer

Colorectal Cancer

Australia, Germany, Greece, Netherlands, Spain
University of Sydney
National Health and Medical Research Council, Australia; Liverpool Cancer Therapy...

Completed

Adaptive CT Acquisition for Personalised Thoracic Imaging (ADAPT)

Cancer, Lung

Australia
Queensland Centre for Gynaecological Cancer
Royal Brisbane and Women's Hospital; Queensland Institute of Medical Research

Completed

Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer (FETCH)

Endometrial Cancer

Australia
Eli Lilly and Company

Terminated

Enzastaurin in Combination of Capecitabine to Treat Breast Cancer

Breast Cancer

Mexico, France, Australia, Argentina, South Africa
Janssen Research & Development, LLC

Recruiting

A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Neoplasms

United States, Australia

Clinical Trials on Ovarian Neoplasms in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations